XML 23 R14.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock Options and Awards
6 Months Ended
Jun. 29, 2024
Stock Options and Awards  
Stock Options and Awards

Note H - Stock Options and Awards

 

On February 19, 2020, the Board of Directors of the Company (the “Board”) adopted The Eastern Company 2020 Stock Incentive Plan (the “2020 Plan”), which replaced The Eastern Company 2010 Executive Stock Incentive Plan after its expiration in February 2020. On April 29, 2020, at the Company’s 2020 Annual Meeting of Shareholders, the shareholders of the Company approved and adopted the 2020 Plan. The Company has no other existing plan pursuant to which equity awards may be granted.

 

Incentive stock options granted under the 2020 Plan must have exercise prices that are not less than 100% of the fair market value of the Company’s common stock on the dates the stock options are granted. Restricted stock awards may also be granted to participants under the 2020 Plan with restrictions determined by the Compensation Committee of the Board. Under the 2020 Plan, non-qualified stock options granted to participants will have exercise prices determined by the Compensation Committee of the Board. During the first six months of fiscal 2024 and 2023, the Company granted stock awards with respect to 92,016 and 64,500 shares of Company common stock, respectively, that were subject to the meeting of performance measurements or time based. For the first six months of fiscal years 2024 and 2023, the Company used fair market value to determine the associated expense with stock awards.

 

The 2020 Plan also permits the issuance of Stock Appreciation Rights (“SARs”). The SARs are in the form of an option with a cashless exercise price equal to the difference between the fair value of the Company’s common stock at the date of grant and the fair value as of the exercise date resulting in the issuance of the Company’s common stock. The Company did not issue any SARs during the first six months of fiscal 2024 and 2023.

 

Stock-based compensation (income) expense, including forfeitures, in connection with SARs and stock awards previously granted to employees was approximately $(20,000) and $21,000 in the second quarter of 2024 and the second quarter of 2023, respectively, and was approximately $414,000 and $(163,000) in the first six months of fiscal years 2024 and 2023, respectively.

 

As of June 29, 2024, there were 792,819 shares of Company common stock reserved and available for future grant under the 2020 Plan.

 

The following tables set forth the outstanding SARs for the period specified:

 

 

 

Six Months Ended

 

 

Year Ended

 

 

 

June 29, 2024

 

 

December 30, 2023

 

 

 

Units

 

 

Weighted Average

Exercise Price

 

 

Units

 

 

Weighted Average

Exercise Price

 

Outstanding at beginning of period

 

 

13,000

 

 

$24.19

 

 

 

146,166

 

 

$23.22

 

Expired

 

 

(9,000)

 

 

26.30

 

 

 

(50,833)

 

 

24.24

 

Exercised

 

 

-

 

 

 

-

 

 

 

(33,333)

 

 

21.10

 

Forfeited

 

 

-

 

 

 

-

 

 

 

(49,000)

 

 

22.80

 

Outstanding at end of period

 

 

4,000

 

 

 

20.20

 

 

 

13,000

 

 

 

24.19

 

 

SARs Outstanding and Exercisable

Range of Exercise Prices

 

 

Outstanding as of June 29, 2024

 

 

Weighted Average Remaining Contractual Life

 

 

Weighted Average Exercise Price

 

 

Exercisable as of June 29, 2024

 

 

Weighted Average Remaining Contractual Life

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

20.20

 

 

 

4,000

 

 

 

0.8

 

 

$20.20

 

 

 

4,000

 

 

 

0.8

 

 

$20.20

 

 

The following tables set forth the outstanding stock awards for the period specified:

 

 

 

Six Months Ended

 

 

Year Ended

 

 

 

June 29, 2024

 

 

December 30, 2023

 

 

 

Shares

 

 

Shares

 

Outstanding at beginning of period

 

 

89,400

 

 

 

64,500

 

Issued

 

 

92,016

 

 

 

82,800

 

Exercised

 

 

(23,734)

 

 

(10,600)

Forfeited

 

 

(11,266)

 

 

(47,300)

Outstanding at end of period

 

 

146,416

 

 

 

89,400

 

 

As of June 29, 2024, outstanding SARs and stock awards had an intrinsic value of $3,750,304.